PEDIASTENT LLC

Medtech · Private

Bioresorbable stents for pediatric aortic coarctation repair, made from zinc alloy or magnesium nanocomposite materials that resorb as the child's cardiovascular structures grow

Grants
$3.0M
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
$3.4M
1 award · Health and Human S
#154 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · Igf::ot::igf The Development Leading To The Commercialization Of A Bioresorbable Stents (brs) For The Treatment Of Coarctation Of The Aorta (coa) In Neonates.$3,399,279
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
151FIELDLINE INC$3.6M—
152AUSCULTECH DX LLC$3.5M—
153BIOSENSICS LLC$3.5M—
154PEDIASTENT LLC$3.4M—
155SPINEOLOGY INC$3.4M$48M
156KEPHERA DIAGNOSTICS LLC$3.3M—
157INNOVATIVE DESIGN LABS INC$3.3M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.